Download PDF
Thromb Haemost 1982; 47(02): 189
DOI: 10.1055/s-0038-1657163
Letter to the Editor
Schattauer GmbH Stuttgart

Platelets, Cardiac Valves and Sulphinpyrazone

E A Loeliger
Interne Geneeskunde, Academisch Ziekenhuis Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 18 January 1982

Accepted 23 February 1982

Publication Date:
13 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Ludlam CA, Allan N, Blandford RB, Dowdle R, Bentley NJ, Bloom AL. Platelet and coagulation function in patients with abnormal cardiac valves treated with Sulphinpyrazone. Thromb Haemostas 1981; 46: 743-746
    PubMedGoogle Scholar
  • 2 Blackburn EK. Long-term anticoagulant therapy. Prescribers’ J 1976; 16: 73-74
    PubMedGoogle Scholar
  • 3 Barkhan P. Therapeutic range with BCTR (letter). Thromb Haemostas 1976; 35: 751
    PubMedGoogle Scholar
  • 4 Loeliger EA. The optimal therapeutic range in oral anticoagulation. History and Proposal. Thromb Haemostas 1979; 42: 1141-1152
    PubMedGoogle Scholar
  • 5 Steele P, Rainwater J. Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease. Circulation 1980; 62: 462-465
    CrossrefPubMedGoogle Scholar
  • 6 Loeliger EA. Sulfinpyrazone and Thromboembolism (letter). Circulation 1981; 64: 1076-1077
    PubMedGoogle Scholar